Company Overview

Development Stage

About the Company

[Summary] 中国动保行业创新发展的推动者

内蒙古金宇集团股份有限公司成立于1993年3月,1999年1月在上海证券交易所上市,股票代码:600201。A股生物制药板块绩优上市公司。截止2014年底集团公司总资产21亿元,员工总数1050人。2014年实现销售收入10.63亿元,实现利润4.04亿元;同比增长58.3和61%。
金宇集团秉承“护佑动物安全,保障人类健康”的崇高使命,奉行“责任、创新、价值”的核心价值观,持续开展管理、技术、产品创新,核心竞争力不断增强。旗下金宇保灵生物药品有限公司和扬州优邦生物制药有限公司均为*高新技术企业。金宇保灵生物药品有限公司为“国家技术创新示范企业”、“中国动保行业协会”副理事长单位,拥有行业*的“兽用疫苗国家工程实验室”,建成了国家高级别生物安全实验室。
 2008年攻克细胞悬浮培养技术难关,率先上马国内*条口蹄疫悬浮培养生产线,引领产业升级。
 2012年为行业制定了口蹄疫疫苗抗原含量、杂蛋白含量、抗原和杂蛋白检测三项标准。
 2013年公司提出“国际化”、“市场化”发展战略,同时埃塞俄比亚项目筹备建设。
 2014年公司与法国诗华、盖茨基金等机构合作,与欧洲、非洲、美洲、哈萨克斯坦、蒙古国等十几个国家,进行了广泛的技术交流和合作,国际化战略正在扎实深入展开、有序落位推进。
 2015年金宇国际生物科技产业园区奠基开工,规划建设高规格口蹄疫悬浮培养生产线和布氏菌病疫苗生产线,主动担当推动国内生物制药行业产品、技术创新的历史使命。
集团公司先后获评全国“上市公司治理100强”、“第四届全国就业与社会保障先进民营企业”、“2015中国责任品牌优秀企业”,自治区首届“百强诚信企业”、“创先争优先进党组织”、“企业文化建设先进单位”,呼和浩特市“优秀本土民营企业”、“劳动关系和谐单位”等殊荣。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

生物股份 Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 上交所

生物股份 How Fast Is Hiring Growing? (61 open positions)

Manage
Note: How fast is hiring at 金宇生物技术股份有限公司 growing? 生物股份2026: 177 openings (up 26%), 2025: 141 openings (up 107%), 2024: 68 openings (up 84%), 2023: 37 openings (up 28%), 2022: 29 openings (up 61%), 2021: 18 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

生物股份 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 60%
  • 2024: Up 36%
  • 2023: Up 22%
  • 2022: Up 80%
生物股份 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 金宇生物技术股份有限公司 growing? 生物股份Master's recruitment over the years: 2025: 6 openings (down 60%), 2024: 15 openings (up 36%), 2023: 11 openings (up 22%), 2022: 9 openings (up 80%), 2021: 5 openings.

生物股份 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
生物股份 Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 金宇生物技术股份有限公司 growing? 生物股份Doctorate recruitment over the years: 2026: 2 openings (up 167%), 2024: 1 openings (up 36%), 2023: 1 openings (up 22%), 2022: 1 openings (up 80%).

生物股份 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 金宇生物技术股份有限公司? Based on an analysis of 生物股份's job postings over the past year, "医疗卫生/美容保健类" demand: 12.8%, "计算机/网络/技术类": 9.9%, "其他(研发和技术类)": 7%, "农林渔类": 6.6%, "生物/制药/化工/环保类": 2.9%, "美术/设计/创意类": 2.1%. For reference only.

生物股份 — What Are the Salaries Like? (243 records)

Manage
salary range: 4.5K - 50K, 42.8% of roles pay ¥8-15K
Note: salary statistics are based on 243 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 金宇生物技术股份有限公司?生物股份42.8% of positions earn 8-15K, Fresh graduate salary: ¥5.3K。Hohhot salary ranking top 10,销售类 average salary ¥14.2K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 生物股份

(More)
Are salaries high at 金宇生物技术股份有限公司? We provide: 销售,人力,兽医,ka,技术服务,国际贸易,bp,培训,贸易专员,资源经理,核算,资金经理,市场,标书,财务,hr,制作,副总,操作工,普工. Click to view detailed salary analysis by job.

生物股份 — Fortune 500? (More)

Yes, ranked in 中国农业500强:

Yes, ranked in 中国企业慈善公益500强:

生物股份 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

生物股份 Related Industry Tags

Job Category

  • 销售类
    30.5% of total 30.5%
  • 经营管理类
    20.3% of total 20.3%
  • 人力资源类
    15.4% of total 15.4%
  • 医疗卫生/美容保健类
    12.6% of total 12.6%

Education

  • 本科
    61.8% of total 61.8%
  • 大专
    23.6% of total 23.6%
  • 硕士
    6.9% of total 6.9%
  • 不限
    6.9% of total 6.9%

Experience

  • 1-3年
    40.7% of total 40.7%
  • 3-5年
    24.8% of total 24.8%
  • 5-10年
    16.3% of total 16.3%
  • 不限
    16.3% of total 16.3%
View Detailed Analysis

What does 金宇生物技术股份有限公司 require? Who is 生物股份 hiring? 生物股份 recruitment: 销售类占比最多占30.5%,其次是经营管理类占20.3%. What education can get in at 生物股份? 本科占比最多占61.8%,其次是大专占23.6%. High education required at 生物股份? 硕士占6.9%,博士占0.8%. Work experience required at 生物股份? 1-3年占比最多占40.7%,其次是3-5年占24.8%. Where are the job locations at 生物股份? 呼和浩特占比最多占52.4%,其次是北京占15.4%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 112,036.9226万(元)
Legal Representative: 张翀宇
Date Established:
Credit Code: 911500001141618816
Registered Address: 内蒙古自治区呼和浩特市经济技术开发区沙尔沁工业园区金宇大街1号

Partners & Suppliers

提供猪用疫苗及兽用生物制品 Source
合作客户 动保疫苗
牧原股份向生物股份采购口蹄疫等疫苗产品 Source
合作客户 动物疫苗
生物股份向牧原股份供应口蹄疫疫苗等 Source
合作客户 疫苗
向牧原股份(包括汝州市牧原农牧有限公司)提供兽用疫苗等产品 Source
合作客户 兽药
提供口蹄疫等疫苗 Source
合作客户 兽药疫苗

People who follow 生物股份 also follow

生物股份 Competitors (Similar Companies)

生物科技/生物工程 生物制品 葡萄糖 复混肥
“Driving the transformation of China's milk source model”
阿维菌素 抗感染药物 抗肿瘤药 精神病药
“A high-tech agricultural and livestock enterprise group with a full in”
“Battery manufacturer”
光学 光电 二极管 光纤激光器
“Large comprehensive food enterprise”
制药/药业 医药 药材种植 中成药
生物科技/生物工程 分子生物学 原代细胞 动物保健品
饮品 饮料 苏打水 食品
乳业 冰淇淋 奶粉 酸奶
铝业 区域经济 铝产业链 铝加工
余热发电 轧钢 重工制造 型钢
医用耗材 手术器械 手术室设备 一次性医用耗材
饲料 饲料生产 农业 生猪养殖

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates